Our clinical trial experience includes but is not limited to the following gastrointestinal indications:
Our global investigator database includes over 1,500 gastrointestinal investigative sites across 50 countries. We have worked with a wealth of specialty investigators in the areas of Abdominal Hernias, Anal and Rectal Conditions, Benign GI Neoplasms, Infections, Inflammations, Motility, Stenosis, Ulceration and Vascular Conditions, Diverticular Disorders, Exocrine Pancreatic Disorders, GI Hemorrhages, Malabsorption, Perotineal and Retroperitoneal Conditions, Salivary Gland Conditions, Tongue Conditions, and Oral Soft Tissue Conditions.
ICON’s Gastrointestinal TAG is comprised of internal therapeutic specialists who are experienced in clinical research and drug development. The Gastrointestinal TAG contains networks with thought leaders, investigators, and clinical professionals throughout the world who are available to consult on individual projects. In addition to providing support and guidance to the study team, the main responsibilities of the TAG teams include: